Solid Biosciences Inc. Members' Equity
Solid Biosciences Inc. (SLDB) had Members' Equity of $145.07 million as of 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Balance Sheet › Equity › Limited Liability Company (LLC) Members' Equity › Members' Equity
us-gaap:MembersEquity · last filed 2019-03-13
- 2018-09-30: Members' Equity $145.07M.
- 2018-06-30: Members' Equity $162.29M.
- 2018-03-31: Members' Equity $178.95M.
- 2017-12-31: Members' Equity -$59.26M.
| Period end | Members' Equity |
|---|---|
| 2018-09-30 | $145.07M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $162.29M 10-Q · filed 2018-08-10 |
| 2018-03-31 | $178.95M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$59.26M 10-K · filed 2019-03-13 |
| 2016-12-31 | -$37.89M 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |